Avian influenza

Avian influenza
Cybercobra (talk) · CC BY-SA 3.0 · source
Name	Avian influenza
Field	Virology, Infectious disease, Epidemiology
Causes	Influenza A viruses of avian origin
Prevention	Biosecurity, vaccination, surveillance
Treatment	Antiviral agents, supportive care

Avian influenza is an infectious disease caused by influenza A viruses that primarily circulate in birds and occasionally infect mammals. Historically associated with severe outbreaks in domestic poultry and sporadic human cases, the condition has generated intensive study across Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Food and Agriculture Organization (FAO), and veterinary research institutions. Responses have involved coordination among United Nations agencies, national ministries such as the United States Department of Agriculture (USDA) and Defra in the United Kingdom, and academic centers including Johns Hopkins University, University of Cambridge, University of Tokyo, and Emory University.

Virology and Subtypes

Influenza A viruses are classified by surface glycoproteins hemagglutinin and neuraminidase, giving subtypes like H5N1, H7N9, and H9N2 that have major roles in outbreaks studied by teams at National Institutes of Health (NIH), Institut Pasteur, and CDC. The segmented negative-sense RNA genome enables reassortment events documented in literature from Rockefeller University, University of Wisconsin–Madison, and Harvard University, and such events underpin emergence narratives involving viruses with novel HA and NA combinations analyzed by groups at Scripps Research, Cold Spring Harbor Laboratory, and Pasteur Institute. Molecular determinants of host range and virulence have been mapped to residues in HA and PB2 by researchers at Max Planck Institute, Imperial College London, and University of Oxford.

Epidemiology and Transmission

Wild aquatic birds such as species monitored by Cornell Lab of Ornithology and RSPB act as reservoirs, with migratory pathways connecting flyways studied by Wetlands International and BirdLife International. Spillover into domestic poultry has driven outbreaks documented in countries including China, Egypt, Vietnam, Indonesia, Nigeria, and Mexico, prompting interventions by FAO and national veterinary services like USDA Animal and Plant Health Inspection Service. Zoonotic transmission to humans has been recorded in settings linked toWuhan live-bird markets and rural backyard flocks, with case investigations undertaken by WHO collaborating centers and national public health institutes such as China CDC and Public Health England. Nosocomial and limited human-to-human transmission concerns have been assessed in reports from ECDC and outbreak response teams at CDC.

Clinical Presentation and Pathogenesis

Clinical syndromes range from asymptomatic infection in some hosts to severe respiratory disease, acute respiratory distress syndrome, and multisystem involvement evidenced in case series from Beijing Tiantan Hospital, Sheikh Khalifa Medical City, and Royal Melbourne Hospital. Pathogenesis studies published by teams at Mount Sinai Health System, Karolinska Institutet, and University of Hong Kong link high viral replication, cytokine dysregulation, and tissue tropism to severe outcomes. Risk factors for severe disease identified in cohorts from Singapore General Hospital, Chiang Mai University Hospital, and Mayo Clinic include age and comorbidities, while extrapulmonary manifestations have been described in clinical reports from Cairo University Hospitals and Addis Ababa University Hospital.

Diagnosis and Surveillance

Diagnostic confirmation relies on molecular assays such as reverse transcription polymerase chain reaction (RT-PCR) developed by laboratories at CDC, WHO Collaborating Centres, and university reference labs including University of California, San Francisco. Virus isolation and sequencing performed at centers like Erasmus MC, Canadian Food Inspection Agency, and Australian Centre for Disease Preparedness support subtype identification and genetic characterization. Integrated surveillance systems combining reports from OIE (World Organisation for Animal Health), FAO, and WHO feed data to platforms used by agencies such as EFSA and national public health institutes to inform risk assessments and control measures.

Prevention and Control Measures

Control in poultry relies on biosecurity protocols promulgated by FAO and implemented by national veterinary authorities including USDA and Defra, culling and movement controls enforced during outbreaks as seen in responses in Netherlands, South Korea, and Japan, and targeted vaccination programs used in China and Egypt. Measures in live-bird markets draw on guidance from WHO, FAO, and local health ministries such as Ministry of Health (China). International trade and animal health standards overseen by OIE and agreements under WTO influence import/export restrictions. Public health mitigation—masking, exposure avoidance, and risk communication—has been coordinated by WHO regional offices and national agencies like CDC.

Treatment and Antiviral Resistance

Antiviral agents such as oseltamivir and zanamivir, developed in part by pharmaceutical companies like Roche and GlaxoSmithKline, are recommended for severe human cases with dosing informed by clinical trials at institutions including NIH and University of Oxford. Resistance mutations in neuraminidase and polymerase genes have emerged and been documented by surveillance consortia at GISAID, Nextstrain, and academic groups at Wellcome Sanger Institute; these findings guide stockpiling and therapeutic policy by WHO and national health agencies. Novel therapeutics and monoclonal antibodies in development have origins in research at Regeneron, Vir Biotechnology, and university spin-offs from MIT and Stanford University.

Impact on Agriculture, Economy, and Public Health

Large poultry epizootics have caused substantial economic losses measured in export disruptions reported by WTO and national ministries of agriculture in United States, European Union member states, and Thailand, while compensation schemes and industry adjustments have involved agencies like World Bank in economic assessments. Public health burdens from human cases have strained hospital capacity in affected regions with reporting from WHO country offices, and the intersection with food security has prompted action by FAO and UNICEF in vulnerable nations. Ongoing research and policy coordination among WHO, FAO, OIE, and national agencies aim to reduce zoonotic risk while protecting livelihoods in poultry-dependent communities.

Category:Influenza A virus infections